

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | retinal cone cell development (GO:0046549) | 9.61256033 |
| 2 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 9.49976391 |
| 3 | rhodopsin mediated signaling pathway (GO:0016056) | 9.36128504 |
| 4 | detection of light stimulus involved in sensory perception (GO:0050962) | 7.60817807 |
| 5 | detection of light stimulus involved in visual perception (GO:0050908) | 7.60817807 |
| 6 | photoreceptor cell development (GO:0042461) | 7.45569862 |
| 7 | eye photoreceptor cell development (GO:0042462) | 7.26841512 |
| 8 | * photoreceptor cell maintenance (GO:0045494) | 6.64337305 |
| 9 | retinal rod cell development (GO:0046548) | 6.57985400 |
| 10 | protein-chromophore linkage (GO:0018298) | 6.30244379 |
| 11 | phototransduction (GO:0007602) | 5.90510398 |
| 12 | detection of light stimulus (GO:0009583) | 5.78297207 |
| 13 | detection of visible light (GO:0009584) | 5.76362090 |
| 14 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 5.68593509 |
| 15 | phototransduction, visible light (GO:0007603) | 5.68386070 |
| 16 | neuron cell-cell adhesion (GO:0007158) | 5.49824277 |
| 17 | * visual perception (GO:0007601) | 5.21103380 |
| 18 | * sensory perception of light stimulus (GO:0050953) | 5.16642036 |
| 19 | positive regulation of guanylate cyclase activity (GO:0031284) | 5.10487276 |
| 20 | presynaptic membrane assembly (GO:0097105) | 4.96838849 |
| 21 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.91033748 |
| 22 | eye photoreceptor cell differentiation (GO:0001754) | 4.87693737 |
| 23 | photoreceptor cell differentiation (GO:0046530) | 4.87693737 |
| 24 | protein localization to synapse (GO:0035418) | 4.58209811 |
| 25 | postsynaptic membrane organization (GO:0001941) | 4.52246002 |
| 26 | regulation of guanylate cyclase activity (GO:0031282) | 4.49847788 |
| 27 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.37336739 |
| 28 | GMP metabolic process (GO:0046037) | 4.36962489 |
| 29 | presynaptic membrane organization (GO:0097090) | 4.32274344 |
| 30 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.31561423 |
| 31 | * detection of external stimulus (GO:0009581) | 4.25011623 |
| 32 | * detection of abiotic stimulus (GO:0009582) | 4.20004769 |
| 33 | regulation of axon regeneration (GO:0048679) | 4.17962554 |
| 34 | regulation of neuron projection regeneration (GO:0070570) | 4.17962554 |
| 35 | locomotory exploration behavior (GO:0035641) | 4.13286355 |
| 36 | regulation of meiosis I (GO:0060631) | 4.07898828 |
| 37 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.03987848 |
| 38 | retina development in camera-type eye (GO:0060041) | 3.95096004 |
| 39 | vocalization behavior (GO:0071625) | 3.91008538 |
| 40 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.87660618 |
| 41 | cellular response to light stimulus (GO:0071482) | 3.71352672 |
| 42 | membrane hyperpolarization (GO:0060081) | 3.70438647 |
| 43 | mechanosensory behavior (GO:0007638) | 3.63211995 |
| 44 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.60256752 |
| 45 | neuronal action potential propagation (GO:0019227) | 3.57305832 |
| 46 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.56209412 |
| 47 | axon ensheathment in central nervous system (GO:0032291) | 3.55342243 |
| 48 | central nervous system myelination (GO:0022010) | 3.55342243 |
| 49 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.55327613 |
| 50 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.55187788 |
| 51 | retina layer formation (GO:0010842) | 3.50680432 |
| 52 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.45110713 |
| 53 | synaptic vesicle exocytosis (GO:0016079) | 3.44612079 |
| 54 | auditory behavior (GO:0031223) | 3.44298516 |
| 55 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.41470519 |
| 56 | phosphorelay signal transduction system (GO:0000160) | 3.41093264 |
| 57 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.39086837 |
| 58 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.38029560 |
| 59 | regulation of cGMP metabolic process (GO:0030823) | 3.35609233 |
| 60 | gamma-aminobutyric acid transport (GO:0015812) | 3.34068356 |
| 61 | synaptic vesicle maturation (GO:0016188) | 3.33101726 |
| 62 | membrane assembly (GO:0071709) | 3.32840864 |
| 63 | positive regulation of membrane potential (GO:0045838) | 3.30557999 |
| 64 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.30304094 |
| 65 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.23657443 |
| 66 | synapse assembly (GO:0007416) | 3.21021775 |
| 67 | behavioral response to ethanol (GO:0048149) | 3.19204631 |
| 68 | regulation of collateral sprouting (GO:0048670) | 3.18020490 |
| 69 | dendritic spine morphogenesis (GO:0060997) | 3.16092548 |
| 70 | response to histamine (GO:0034776) | 3.15624307 |
| 71 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.11242842 |
| 72 | positive regulation of neurotransmitter transport (GO:0051590) | 3.09961303 |
| 73 | neuron recognition (GO:0008038) | 3.09826365 |
| 74 | long-term synaptic potentiation (GO:0060291) | 3.08649397 |
| 75 | cAMP catabolic process (GO:0006198) | 3.06877876 |
| 76 | regulation of synaptic vesicle transport (GO:1902803) | 3.05651446 |
| 77 | limb bud formation (GO:0060174) | 3.04457585 |
| 78 | dermatan sulfate biosynthetic process (GO:0030208) | 3.04319493 |
| 79 | cellular potassium ion homeostasis (GO:0030007) | 3.03696490 |
| 80 | axonal fasciculation (GO:0007413) | 3.03298877 |
| 81 | regulation of cGMP biosynthetic process (GO:0030826) | 3.03256806 |
| 82 | innervation (GO:0060384) | 3.02196675 |
| 83 | glutamate secretion (GO:0014047) | 3.01118957 |
| 84 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.00847820 |
| 85 | positive regulation of meiosis (GO:0045836) | 2.98857617 |
| 86 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.97827187 |
| 87 | regulation of respiratory system process (GO:0044065) | 2.96366113 |
| 88 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 2.96102157 |
| 89 | regulation of neurotransmitter secretion (GO:0046928) | 2.95960706 |
| 90 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.94086775 |
| 91 | response to pheromone (GO:0019236) | 2.93899170 |
| 92 | estrogen biosynthetic process (GO:0006703) | 2.93393697 |
| 93 | oligodendrocyte differentiation (GO:0048709) | 2.93383481 |
| 94 | cyclic nucleotide catabolic process (GO:0009214) | 2.92631161 |
| 95 | positive regulation of synapse assembly (GO:0051965) | 2.90819273 |
| 96 | regulation of postsynaptic membrane potential (GO:0060078) | 2.90745230 |
| 97 | nucleobase catabolic process (GO:0046113) | 2.90107392 |
| 98 | neuron-neuron synaptic transmission (GO:0007270) | 2.89957994 |
| 99 | * sensory perception (GO:0007600) | 2.89467320 |
| 100 | synaptic transmission, glutamatergic (GO:0035249) | 2.88830383 |
| 101 | regulation of G-protein coupled receptor protein signaling pathway (GO:0008277) | 2.88765221 |
| 102 | positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742) | 2.87562628 |
| 103 | neuronal action potential (GO:0019228) | 2.86116006 |
| 104 | short-term memory (GO:0007614) | 2.86111165 |
| 105 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 2.84554535 |
| 106 | astrocyte differentiation (GO:0048708) | 2.83722895 |
| 107 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.82390343 |
| 108 | positive regulation of cGMP metabolic process (GO:0030825) | 2.82347569 |
| 109 | protein K11-linked deubiquitination (GO:0035871) | 2.82288636 |
| 110 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.82238471 |
| 111 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.81134252 |
| 112 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.78041650 |
| 113 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.78017799 |
| 114 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.77966211 |
| 115 | glutamate receptor signaling pathway (GO:0007215) | 2.77326440 |
| 116 | positive regulation of meiotic cell cycle (GO:0051446) | 2.77147332 |
| 117 | exploration behavior (GO:0035640) | 2.76898920 |
| 118 | neuron development (GO:0048666) | 2.75192207 |
| 119 | amino acid import (GO:0043090) | 2.74527843 |
| 120 | C4-dicarboxylate transport (GO:0015740) | 2.73397350 |
| 121 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.72946222 |
| 122 | neurotransmitter transport (GO:0006836) | 2.71757980 |
| 123 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.71753617 |
| 124 | membrane depolarization during action potential (GO:0086010) | 2.71013058 |
| 125 | dendrite morphogenesis (GO:0048813) | 2.70775847 |
| 126 | negative regulation of neurotransmitter transport (GO:0051589) | 2.69837619 |
| 127 | piRNA metabolic process (GO:0034587) | 2.69329805 |
| 128 | L-amino acid import (GO:0043092) | 2.68227516 |
| 129 | Sertoli cell development (GO:0060009) | 2.68135827 |
| 130 | transmission of nerve impulse (GO:0019226) | 2.67751776 |
| 131 | regulation of neurotransmitter transport (GO:0051588) | 2.65941717 |
| 132 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.65904786 |
| 133 | dermatan sulfate metabolic process (GO:0030205) | 2.65881609 |
| 134 | central nervous system neuron axonogenesis (GO:0021955) | 2.65635079 |
| 135 | chemosensory behavior (GO:0007635) | 2.64373323 |
| 136 | calcium ion import (GO:0070509) | 2.63809336 |
| 137 | limb development (GO:0060173) | 2.63297103 |
| 138 | appendage development (GO:0048736) | 2.63297103 |
| 139 | neurotransmitter secretion (GO:0007269) | 2.62709661 |
| 140 | * nonmotile primary cilium assembly (GO:0035058) | 2.62326182 |
| 141 | * startle response (GO:0001964) | 2.61768739 |
| 142 | positive regulation of ERBB signaling pathway (GO:1901186) | 2.61704537 |
| 143 | establishment of protein localization to Golgi (GO:0072600) | 2.60226877 |
| 144 | potassium ion homeostasis (GO:0055075) | 2.59663609 |
| 145 | response to auditory stimulus (GO:0010996) | 2.58697852 |
| 146 | behavioral response to cocaine (GO:0048148) | 2.58286636 |
| 147 | behavioral response to nicotine (GO:0035095) | 2.57471915 |
| 148 | cellular response to sterol (GO:0036315) | 2.53485404 |
| 149 | positive regulation of neurological system process (GO:0031646) | 2.52685530 |
| 150 | synapse organization (GO:0050808) | 2.51149722 |
| 151 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.48548128 |
| 152 | action potential (GO:0001508) | 2.45597908 |
| 153 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.45253266 |
| 154 | spinal cord motor neuron differentiation (GO:0021522) | 2.45039537 |
| 155 | microtubule polymerization or depolymerization (GO:0031109) | 2.44030807 |
| 156 | neural tube formation (GO:0001841) | 2.43789322 |
| 157 | glycosphingolipid biosynthetic process (GO:0006688) | 2.43777768 |
| 158 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.43628026 |
| 159 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.40605323 |
| 160 | negative regulation of axon extension (GO:0030517) | 2.37482095 |
| 161 | * detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.36820876 |
| 162 | * adult walking behavior (GO:0007628) | 2.35212105 |
| 163 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.34080686 |
| 164 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.33659107 |
| 165 | regulation of timing of cell differentiation (GO:0048505) | 2.33586582 |
| 166 | negative regulation of inclusion body assembly (GO:0090084) | 2.32925352 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * GBX2_23144817_ChIP-Seq_PC3_Human | 4.09025463 |
| 2 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.49470708 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.06913213 |
| 4 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.54771510 |
| 5 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.52882763 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.50400814 |
| 7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.42824441 |
| 8 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.37684861 |
| 9 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.18282163 |
| 10 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.14668217 |
| 11 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.13405231 |
| 12 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.13405231 |
| 13 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.10647518 |
| 14 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.08746152 |
| 15 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.06654481 |
| 16 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.05181877 |
| 17 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.02224755 |
| 18 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.02218782 |
| 19 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.00080215 |
| 20 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.99908704 |
| 21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.95334723 |
| 22 | VDR_22108803_ChIP-Seq_LS180_Human | 1.94208980 |
| 23 | EWS_26573619_Chip-Seq_HEK293_Human | 1.94149245 |
| 24 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.92190412 |
| 25 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.90879526 |
| 26 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.90784692 |
| 27 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.89503539 |
| 28 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.87157443 |
| 29 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.87152036 |
| 30 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.87021040 |
| 31 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.86981537 |
| 32 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.85676582 |
| 33 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.82114235 |
| 34 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.81474919 |
| 35 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.79788197 |
| 36 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.79521713 |
| 37 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.75149274 |
| 38 | P300_19829295_ChIP-Seq_ESCs_Human | 1.70695396 |
| 39 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.67420226 |
| 40 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.67018989 |
| 41 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.65551882 |
| 42 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.65177856 |
| 43 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.63212193 |
| 44 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.61349558 |
| 45 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.55010405 |
| 46 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.48596750 |
| 47 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.46766260 |
| 48 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.46319726 |
| 49 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.45411475 |
| 50 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.45002926 |
| 51 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.44813828 |
| 52 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.43958618 |
| 53 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.43273424 |
| 54 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.38422604 |
| 55 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.35493587 |
| 56 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.35446905 |
| 57 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.35420293 |
| 58 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.35222863 |
| 59 | FUS_26573619_Chip-Seq_HEK293_Human | 1.34765673 |
| 60 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.33803380 |
| 61 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.33636814 |
| 62 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.32965327 |
| 63 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.32123913 |
| 64 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.31393964 |
| 65 | * KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.30916630 |
| 66 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.28543532 |
| 67 | AR_25329375_ChIP-Seq_VCAP_Human | 1.27549003 |
| 68 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.25583494 |
| 69 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.24512800 |
| 70 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.24033494 |
| 71 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.22561676 |
| 72 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.22545029 |
| 73 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.21557177 |
| 74 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.21229759 |
| 75 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.20978428 |
| 76 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.20932588 |
| 77 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.20749433 |
| 78 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.20642964 |
| 79 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.19908525 |
| 80 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.19908525 |
| 81 | TP53_16413492_ChIP-PET_HCT116_Human | 1.19201802 |
| 82 | * MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.17769690 |
| 83 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.17660319 |
| 84 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.17660319 |
| 85 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.17343832 |
| 86 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.15341915 |
| 87 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15338702 |
| 88 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.14969014 |
| 89 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.14607436 |
| 90 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.14147171 |
| 91 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.12467568 |
| 92 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12286683 |
| 93 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.12212135 |
| 94 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.12089302 |
| 95 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.12072992 |
| 96 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.12010893 |
| 97 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.11658953 |
| 98 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.11149262 |
| 99 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.10368620 |
| 100 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.10145894 |
| 101 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.09540726 |
| 102 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.09449706 |
| 103 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.09197897 |
| 104 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.08012914 |
| 105 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.07961574 |
| 106 | * AR_19668381_ChIP-Seq_PC3_Human | 1.07897826 |
| 107 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.07495855 |
| 108 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.07454764 |
| 109 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.05267448 |
| 110 | * KDM2B_26808549_Chip-Seq_REH_Human | 1.04779050 |
| 111 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.04509876 |
| 112 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.02890402 |
| 113 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.02711139 |
| 114 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.01989935 |
| 115 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.00913408 |
| 116 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.98864332 |
| 117 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.98803034 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005551_abnormal_eye_electrophysiolog | 7.09039205 |
| 2 | MP0003011_delayed_dark_adaptation | 6.30093378 |
| 3 | MP0006072_abnormal_retinal_apoptosis | 4.80618549 |
| 4 | MP0005253_abnormal_eye_physiology | 4.74621782 |
| 5 | MP0003880_abnormal_central_pattern | 4.05402650 |
| 6 | MP0005423_abnormal_somatic_nervous | 3.88129812 |
| 7 | MP0005195_abnormal_posterior_eye | 2.80802317 |
| 8 | MP0002090_abnormal_vision | 2.55354820 |
| 9 | MP0003950_abnormal_plasma_membrane | 2.41926108 |
| 10 | MP0002638_abnormal_pupillary_reflex | 2.34751119 |
| 11 | * MP0001486_abnormal_startle_reflex | 2.30414846 |
| 12 | MP0004859_abnormal_synaptic_plasticity | 2.20281925 |
| 13 | * MP0002229_neurodegeneration | 2.19698403 |
| 14 | MP0001324_abnormal_eye_pigmentation | 2.19245016 |
| 15 | MP0004147_increased_porphyrin_level | 2.18751739 |
| 16 | MP0003635_abnormal_synaptic_transmissio | 2.15135478 |
| 17 | MP0001984_abnormal_olfaction | 2.13501570 |
| 18 | MP0005391_vision/eye_phenotype | 2.12500162 |
| 19 | MP0004270_analgesia | 2.10491358 |
| 20 | MP0008057_abnormal_DNA_replication | 2.09927397 |
| 21 | MP0001968_abnormal_touch/_nociception | 2.07715361 |
| 22 | MP0001502_abnormal_circadian_rhythm | 2.02176799 |
| 23 | MP0008877_abnormal_DNA_methylation | 1.96529221 |
| 24 | MP0005646_abnormal_pituitary_gland | 1.96308066 |
| 25 | MP0005645_abnormal_hypothalamus_physiol | 1.94889217 |
| 26 | MP0009745_abnormal_behavioral_response | 1.92407967 |
| 27 | MP0002272_abnormal_nervous_system | 1.90998727 |
| 28 | MP0006292_abnormal_olfactory_placode | 1.88432962 |
| 29 | MP0002064_seizures | 1.88039494 |
| 30 | MP0002734_abnormal_mechanical_nocicepti | 1.84902881 |
| 31 | MP0001986_abnormal_taste_sensitivity | 1.81079891 |
| 32 | * MP0002752_abnormal_somatic_nervous | 1.79146612 |
| 33 | MP0009046_muscle_twitch | 1.77686582 |
| 34 | MP0002063_abnormal_learning/memory/cond | 1.72440280 |
| 35 | MP0002572_abnormal_emotion/affect_behav | 1.71063054 |
| 36 | MP0002736_abnormal_nociception_after | 1.64370411 |
| 37 | * MP0002882_abnormal_neuron_morphology | 1.62052763 |
| 38 | MP0003195_calcinosis | 1.52358655 |
| 39 | MP0003183_abnormal_peptide_metabolism | 1.52003325 |
| 40 | * MP0002067_abnormal_sensory_capabilities | 1.50107421 |
| 41 | MP0001485_abnormal_pinna_reflex | 1.42245055 |
| 42 | MP0002653_abnormal_ependyma_morphology | 1.39547021 |
| 43 | MP0010386_abnormal_urinary_bladder | 1.29179108 |
| 44 | MP0000778_abnormal_nervous_system | 1.25292845 |
| 45 | MP0005386_behavior/neurological_phenoty | 1.22412547 |
| 46 | MP0004924_abnormal_behavior | 1.22412547 |
| 47 | MP0004885_abnormal_endolymph | 1.21783592 |
| 48 | MP0002557_abnormal_social/conspecific_i | 1.21673395 |
| 49 | MP0003136_yellow_coat_color | 1.20991614 |
| 50 | MP0000631_abnormal_neuroendocrine_gland | 1.20724947 |
| 51 | MP0001501_abnormal_sleep_pattern | 1.19757740 |
| 52 | MP0001188_hyperpigmentation | 1.19356796 |
| 53 | MP0002184_abnormal_innervation | 1.18354644 |
| 54 | MP0003634_abnormal_glial_cell | 1.18258024 |
| 55 | * MP0004742_abnormal_vestibular_system | 1.12365289 |
| 56 | MP0003172_abnormal_lysosome_physiology | 1.11518670 |
| 57 | MP0004142_abnormal_muscle_tone | 1.11260083 |
| 58 | MP0001970_abnormal_pain_threshold | 1.10782020 |
| 59 | MP0003283_abnormal_digestive_organ | 1.07862569 |
| 60 | MP0002751_abnormal_autonomic_nervous | 1.06684427 |
| 61 | MP0003121_genomic_imprinting | 1.05615528 |
| 62 | MP0006276_abnormal_autonomic_nervous | 1.04924777 |
| 63 | MP0003119_abnormal_digestive_system | 1.04223933 |
| 64 | * MP0001963_abnormal_hearing_physiology | 1.04110757 |
| 65 | MP0004043_abnormal_pH_regulation | 1.00180422 |
| 66 | MP0000920_abnormal_myelination | 1.00020626 |
| 67 | MP0005187_abnormal_penis_morphology | 0.97468423 |
| 68 | MP0002735_abnormal_chemical_nociception | 0.97002111 |
| 69 | MP0003718_maternal_effect | 0.96160462 |
| 70 | MP0001529_abnormal_vocalization | 0.94647746 |
| 71 | MP0008569_lethality_at_weaning | 0.94017955 |
| 72 | MP0002234_abnormal_pharynx_morphology | 0.92674303 |
| 73 | MP0002733_abnormal_thermal_nociception | 0.91052021 |
| 74 | MP0005409_darkened_coat_color | 0.88507068 |
| 75 | MP0008872_abnormal_physiological_respon | 0.87451572 |
| 76 | MP0001905_abnormal_dopamine_level | 0.86329572 |
| 77 | MP0004133_heterotaxia | 0.85265641 |
| 78 | MP0001440_abnormal_grooming_behavior | 0.84401737 |
| 79 | MP0009780_abnormal_chondrocyte_physiolo | 0.83718425 |
| 80 | * MP0002066_abnormal_motor_capabilities/c | 0.83032450 |
| 81 | MP0003890_abnormal_embryonic-extraembry | 0.82910787 |
| 82 | * MP0000026_abnormal_inner_ear | 0.81850830 |
| 83 | MP0001764_abnormal_homeostasis | 0.81067087 |
| 84 | MP0002102_abnormal_ear_morphology | 0.80751010 |
| 85 | MP0000955_abnormal_spinal_cord | 0.80658549 |
| 86 | MP0003879_abnormal_hair_cell | 0.79678376 |
| 87 | MP0003861_abnormal_nervous_system | 0.78212810 |
| 88 | MP0005171_absent_coat_pigmentation | 0.77535012 |
| 89 | MP0008004_abnormal_stomach_pH | 0.76405259 |
| 90 | MP0005174_abnormal_tail_pigmentation | 0.75607391 |
| 91 | MP0003698_abnormal_male_reproductive | 0.75268131 |
| 92 | MP0002210_abnormal_sex_determination | 0.74964983 |
| 93 | MP0001929_abnormal_gametogenesis | 0.74784696 |
| 94 | MP0005167_abnormal_blood-brain_barrier | 0.74650338 |
| 95 | MP0000639_abnormal_adrenal_gland | 0.74484821 |
| 96 | MP0003941_abnormal_skin_development | 0.73980198 |
| 97 | MP0003690_abnormal_glial_cell | 0.73505114 |
| 98 | MP0002909_abnormal_adrenal_gland | 0.71888168 |
| 99 | MP0000427_abnormal_hair_cycle | 0.71804360 |
| 100 | MP0003122_maternal_imprinting | 0.71768078 |
| 101 | MP0003787_abnormal_imprinting | 0.71075595 |
| 102 | MP0005394_taste/olfaction_phenotype | 0.70697590 |
| 103 | MP0005499_abnormal_olfactory_system | 0.70697590 |
| 104 | MP0003633_abnormal_nervous_system | 0.70079499 |
| 105 | MP0000049_abnormal_middle_ear | 0.69911926 |
| 106 | MP0002152_abnormal_brain_morphology | 0.68732264 |
| 107 | MP0004811_abnormal_neuron_physiology | 0.66902959 |
| 108 | MP0004782_abnormal_surfactant_physiolog | 0.65427579 |
| 109 | MP0001177_atelectasis | 0.64729217 |
| 110 | MP0004145_abnormal_muscle_electrophysio | 0.64430505 |
| 111 | MP0003631_nervous_system_phenotype | 0.63819637 |
| 112 | MP0004858_abnormal_nervous_system | 0.60884034 |
| 113 | MP0003632_abnormal_nervous_system | 0.60205599 |
| 114 | MP0005248_abnormal_Harderian_gland | 0.60002485 |
| 115 | MP0008260_abnormal_autophagy | 0.59938610 |
| 116 | MP0000569_abnormal_digit_pigmentation | 0.57559939 |
| 117 | MP0005197_abnormal_uvea_morphology | 0.57374147 |
| 118 | MP0002332_abnormal_exercise_endurance | 0.54539105 |
| 119 | MP0008789_abnormal_olfactory_epithelium | 0.49028983 |
| 120 | MP0005379_endocrine/exocrine_gland_phen | 0.48943675 |
| 121 | MP0002069_abnormal_eating/drinking_beha | 0.48347449 |
| 122 | MP0004085_abnormal_heartbeat | 0.48318517 |
| 123 | MP0004019_abnormal_vitamin_homeostasis | 0.46352569 |
| 124 | MP0001299_abnormal_eye_distance/ | 0.43956061 |
| 125 | MP0004215_abnormal_myocardial_fiber | 0.43462218 |
| 126 | MP0005535_abnormal_body_temperature | 0.42429357 |
| 127 | MP0002277_abnormal_respiratory_mucosa | 0.42094254 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 8.80556818 |
| 2 | Dyschromatopsia (HP:0007641) | 8.72491892 |
| 3 | Abnormal rod and cone electroretinograms (HP:0008323) | 8.25317665 |
| 4 | Bony spicule pigmentary retinopathy (HP:0007737) | 8.20955257 |
| 5 | Central scotoma (HP:0000603) | 7.22351549 |
| 6 | Abnormality of macular pigmentation (HP:0008002) | 7.18747078 |
| 7 | Pigmentary retinal degeneration (HP:0001146) | 6.67654841 |
| 8 | Decreased central vision (HP:0007663) | 6.60704283 |
| 9 | Pendular nystagmus (HP:0012043) | 6.42722867 |
| 10 | Abolished electroretinogram (ERG) (HP:0000550) | 6.26594775 |
| 11 | Scotoma (HP:0000575) | 6.22521346 |
| 12 | Chorioretinal atrophy (HP:0000533) | 5.97143992 |
| 13 | Attenuation of retinal blood vessels (HP:0007843) | 5.96676480 |
| 14 | Severe visual impairment (HP:0001141) | 5.40585744 |
| 15 | Photophobia (HP:0000613) | 4.68905743 |
| 16 | Macular degeneration (HP:0000608) | 4.58672156 |
| 17 | Increased corneal curvature (HP:0100692) | 4.42035287 |
| 18 | Keratoconus (HP:0000563) | 4.42035287 |
| 19 | Vitreoretinal degeneration (HP:0000655) | 4.24896872 |
| 20 | Type II diabetes mellitus (HP:0005978) | 4.17962697 |
| 21 | Choroideremia (HP:0001139) | 4.13083071 |
| 22 | Constricted visual fields (HP:0001133) | 3.80207577 |
| 23 | Genetic anticipation (HP:0003743) | 3.75023028 |
| 24 | Cone-rod dystrophy (HP:0000548) | 3.62836783 |
| 25 | * Retinitis pigmentosa (HP:0000510) | 3.45419368 |
| 26 | Posterior subcapsular cataract (HP:0007787) | 3.12994283 |
| 27 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.07979827 |
| 28 | Hemiparesis (HP:0001269) | 2.93509813 |
| 29 | Abnormality of the labia minora (HP:0012880) | 2.93050402 |
| 30 | Epileptic encephalopathy (HP:0200134) | 2.91489276 |
| 31 | Abnormality of midbrain morphology (HP:0002418) | 2.86804388 |
| 32 | Molar tooth sign on MRI (HP:0002419) | 2.86804388 |
| 33 | Febrile seizures (HP:0002373) | 2.84652111 |
| 34 | Megalencephaly (HP:0001355) | 2.78845707 |
| 35 | Gait imbalance (HP:0002141) | 2.69850212 |
| 36 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.67457039 |
| 37 | Progressive visual loss (HP:0000529) | 2.67234022 |
| 38 | Focal motor seizures (HP:0011153) | 2.65970803 |
| 39 | Congenital primary aphakia (HP:0007707) | 2.58651246 |
| 40 | Retinal atrophy (HP:0001105) | 2.54124072 |
| 41 | Abnormality of the ischium (HP:0003174) | 2.53479882 |
| 42 | True hermaphroditism (HP:0010459) | 2.42155293 |
| 43 | Hepatoblastoma (HP:0002884) | 2.41620434 |
| 44 | Medial flaring of the eyebrow (HP:0010747) | 2.40525648 |
| 45 | Nephrogenic diabetes insipidus (HP:0009806) | 2.37091102 |
| 46 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.37074133 |
| 47 | Optic disc pallor (HP:0000543) | 2.35851341 |
| 48 | Hyperventilation (HP:0002883) | 2.28157376 |
| 49 | Nephronophthisis (HP:0000090) | 2.24347428 |
| 50 | Supernumerary spleens (HP:0009799) | 2.22663053 |
| 51 | Hypoplastic labia majora (HP:0000059) | 2.21060251 |
| 52 | Pancreatic fibrosis (HP:0100732) | 2.19222584 |
| 53 | Oligodactyly (HP:0012165) | 2.17808128 |
| 54 | Aqueductal stenosis (HP:0002410) | 2.16326004 |
| 55 | Hypoplastic ischia (HP:0003175) | 2.12036257 |
| 56 | Alacrima (HP:0000522) | 2.09190051 |
| 57 | Oligodactyly (hands) (HP:0001180) | 2.08391637 |
| 58 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 2.08391090 |
| 59 | Progressive cerebellar ataxia (HP:0002073) | 2.06863783 |
| 60 | Intestinal atresia (HP:0011100) | 2.05933765 |
| 61 | Action tremor (HP:0002345) | 2.05758393 |
| 62 | Retinal dysplasia (HP:0007973) | 2.04012287 |
| 63 | * Congenital sensorineural hearing impairment (HP:0008527) | 2.03016543 |
| 64 | Cupped ear (HP:0000378) | 2.02948142 |
| 65 | Type II lissencephaly (HP:0007260) | 2.00766813 |
| 66 | Congenital stationary night blindness (HP:0007642) | 11.4679432 |
| 67 | Poor coordination (HP:0002370) | 1.99819673 |
| 68 | Limb dystonia (HP:0002451) | 1.99263446 |
| 69 | Septo-optic dysplasia (HP:0100842) | 1.98804886 |
| 70 | Labial hypoplasia (HP:0000066) | 1.98778206 |
| 71 | Dysdiadochokinesis (HP:0002075) | 1.98521013 |
| 72 | Anencephaly (HP:0002323) | 1.97935801 |
| 73 | Abnormality of the labia majora (HP:0012881) | 1.97490008 |
| 74 | Hemiplegia (HP:0002301) | 1.97396896 |
| 75 | Absent speech (HP:0001344) | 1.96399427 |
| 76 | Vaginal atresia (HP:0000148) | 1.96327535 |
| 77 | Gonadotropin excess (HP:0000837) | 1.95758914 |
| 78 | Wide nasal bridge (HP:0000431) | 1.94630802 |
| 79 | Abnormality of the renal medulla (HP:0100957) | 1.94277348 |
| 80 | Subcapsular cataract (HP:0000523) | 1.93809170 |
| 81 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.93627445 |
| 82 | Hypoplasia of the fovea (HP:0007750) | 1.93627445 |
| 83 | Genital tract atresia (HP:0001827) | 1.93599691 |
| 84 | Epileptiform EEG discharges (HP:0011182) | 1.92437274 |
| 85 | Broad-based gait (HP:0002136) | 1.92101797 |
| 86 | Enlarged penis (HP:0000040) | 1.91133562 |
| 87 | Abnormal sex determination (HP:0012244) | 1.91082467 |
| 88 | Sex reversal (HP:0012245) | 1.91082467 |
| 89 | Polyphagia (HP:0002591) | 1.88903828 |
| 90 | Decreased circulating renin level (HP:0003351) | 1.86400947 |
| 91 | EEG with generalized epileptiform discharges (HP:0011198) | 1.85935934 |
| 92 | Polydipsia (HP:0001959) | 1.85003317 |
| 93 | Abnormal drinking behavior (HP:0030082) | 1.85003317 |
| 94 | Hypsarrhythmia (HP:0002521) | 1.84629580 |
| 95 | Facial hemangioma (HP:0000329) | 1.83314069 |
| 96 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.82424828 |
| 97 | Increased circulating renin level (HP:0000848) | 1.80268555 |
| 98 | Decreased lacrimation (HP:0000633) | 1.80066145 |
| 99 | Chronic hepatic failure (HP:0100626) | 1.78600951 |
| 100 | Abnormality of the fovea (HP:0000493) | 1.76558834 |
| 101 | Midline defect of the nose (HP:0004122) | 1.75873724 |
| 102 | Short tibia (HP:0005736) | 1.75820350 |
| 103 | Hypoplastic female external genitalia (HP:0012815) | 1.75319396 |
| 104 | Narrow forehead (HP:0000341) | 1.75179016 |
| 105 | Abnormality of the pubic bones (HP:0003172) | 1.72319685 |
| 106 | Tented upper lip vermilion (HP:0010804) | 1.71974512 |
| 107 | Male pseudohermaphroditism (HP:0000037) | 1.71089399 |
| 108 | Congenital hepatic fibrosis (HP:0002612) | 1.70385618 |
| 109 | Laryngomalacia (HP:0001601) | 1.69670487 |
| 110 | Pancreatic cysts (HP:0001737) | 1.68879232 |
| 111 | Postaxial foot polydactyly (HP:0001830) | 1.68553039 |
| 112 | Abnormality of the renal cortex (HP:0011035) | 1.68308233 |
| 113 | Abnormality of the corticospinal tract (HP:0002492) | 1.68254545 |
| 114 | Myokymia (HP:0002411) | 1.66260774 |
| 115 | Focal seizures (HP:0007359) | 1.65379157 |
| 116 | Visual hallucinations (HP:0002367) | 1.64209770 |
| 117 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.60512774 |
| 118 | Optic nerve hypoplasia (HP:0000609) | 1.55947802 |
| 119 | Gaze-evoked nystagmus (HP:0000640) | 1.54930399 |
| 120 | Peripheral hypomyelination (HP:0007182) | 1.49688256 |
| 121 | Severe Myopia (HP:0011003) | 1.45768685 |
| 122 | Macroorchidism (HP:0000053) | 1.45193740 |
| 123 | Chorioretinal coloboma (HP:0000567) | 1.44191149 |
| 124 | Blue irides (HP:0000635) | 1.44096152 |
| 125 | Astigmatism (HP:0000483) | 1.43797571 |
| 126 | Specific learning disability (HP:0001328) | 1.43133816 |
| 127 | Horizontal nystagmus (HP:0000666) | 1.40137635 |
| 128 | Generalized tonic-clonic seizures (HP:0002069) | 1.39667375 |
| 129 | Cystic liver disease (HP:0006706) | 1.39248531 |
| 130 | Absence seizures (HP:0002121) | 1.37185294 |
| 131 | Drooling (HP:0002307) | 1.35248951 |
| 132 | Excessive salivation (HP:0003781) | 1.35248951 |
| 133 | Optic atrophy (HP:0000648) | 1.33679649 |
| 134 | Poor eye contact (HP:0000817) | 1.33385432 |
| 135 | Protruding tongue (HP:0010808) | 1.31685267 |
| 136 | Atonic seizures (HP:0010819) | 1.29850619 |
| 137 | Inappropriate behavior (HP:0000719) | 1.29405465 |
| 138 | Synostosis involving the elbow (HP:0003938) | 1.27556531 |
| 139 | Humeroradial synostosis (HP:0003041) | 1.27556531 |
| 140 | Widely spaced teeth (HP:0000687) | 1.27443196 |
| 141 | Abnormality of the nasal septum (HP:0000419) | 1.25809762 |
| 142 | Sclerocornea (HP:0000647) | 1.25218163 |
| 143 | Short foot (HP:0001773) | 1.25049407 |
| 144 | Dialeptic seizures (HP:0011146) | 1.23336430 |
| 145 | Anxiety (HP:0000739) | 1.20188422 |
| 146 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 1.19860303 |
| 147 | Absent septum pellucidum (HP:0001331) | 1.19225292 |
| 148 | Depression (HP:0000716) | 1.19032004 |
| 149 | Truncal ataxia (HP:0002078) | 1.18963641 |
| 150 | Supranuclear gaze palsy (HP:0000605) | 1.18304655 |
| 151 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.18241425 |
| 152 | Corneal dystrophy (HP:0001131) | 1.18026070 |
| 153 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.17752145 |
| 154 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.17637121 |
| 155 | Postaxial hand polydactyly (HP:0001162) | 1.17592562 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 7.28172461 |
| 2 | GRK1 | 4.99379260 |
| 3 | NTRK3 | 2.62676295 |
| 4 | MAP2K7 | 2.27447452 |
| 5 | PBK | 2.25755699 |
| 6 | TNIK | 2.24093036 |
| 7 | MAP3K4 | 2.19961806 |
| 8 | INSRR | 2.11632585 |
| 9 | MARK1 | 2.02776912 |
| 10 | ACVR1B | 1.88622437 |
| 11 | PHKG2 | 1.61645067 |
| 12 | PHKG1 | 1.61645067 |
| 13 | PINK1 | 1.57973869 |
| 14 | PRPF4B | 1.57275243 |
| 15 | EPHA4 | 1.53651923 |
| 16 | NTRK2 | 1.47560109 |
| 17 | IRAK2 | 1.47313557 |
| 18 | SGK223 | 1.41650707 |
| 19 | SGK494 | 1.41650707 |
| 20 | WEE1 | 1.38872773 |
| 21 | PAK3 | 1.35255490 |
| 22 | SGK2 | 1.29809718 |
| 23 | CAMK1G | 1.29551678 |
| 24 | PAK6 | 1.28178843 |
| 25 | MAPK13 | 1.26916565 |
| 26 | BMPR2 | 1.26464776 |
| 27 | AKT3 | 1.24846241 |
| 28 | ADRBK2 | 1.21018001 |
| 29 | PNCK | 1.20879843 |
| 30 | RIPK4 | 1.20479427 |
| 31 | MKNK2 | 1.19969542 |
| 32 | SIK2 | 1.18771188 |
| 33 | STK38 | 1.17876371 |
| 34 | PLK4 | 1.17585565 |
| 35 | NUAK1 | 1.16935665 |
| 36 | NEK6 | 1.14137035 |
| 37 | CDK3 | 1.13779127 |
| 38 | MAP3K13 | 1.12132699 |
| 39 | MAPK7 | 1.06133217 |
| 40 | MUSK | 1.04482801 |
| 41 | PKN1 | 1.04361135 |
| 42 | ADRBK1 | 0.98696796 |
| 43 | CAMK2G | 0.98171302 |
| 44 | GRK5 | 0.97666737 |
| 45 | PLK2 | 0.97392797 |
| 46 | CAMK2A | 0.95460458 |
| 47 | HIPK2 | 0.90164094 |
| 48 | YES1 | 0.90080659 |
| 49 | STK39 | 0.89396220 |
| 50 | CDK5 | 0.88601881 |
| 51 | TGFBR1 | 0.88064423 |
| 52 | MAP3K9 | 0.87305523 |
| 53 | CSNK1G2 | 0.87080752 |
| 54 | TNK2 | 0.83560311 |
| 55 | MAP2K4 | 0.82564332 |
| 56 | SGK3 | 0.82272888 |
| 57 | ERBB3 | 0.81919252 |
| 58 | GRK7 | 0.81896004 |
| 59 | CAMK2D | 0.81742247 |
| 60 | OXSR1 | 0.81367948 |
| 61 | DAPK2 | 0.80367913 |
| 62 | DYRK2 | 0.80335749 |
| 63 | FGFR2 | 0.80058632 |
| 64 | MAP3K12 | 0.80026686 |
| 65 | CAMK1D | 0.78074122 |
| 66 | DYRK1A | 0.78016507 |
| 67 | CSNK1G1 | 0.75450406 |
| 68 | NTRK1 | 0.74820948 |
| 69 | TIE1 | 0.71751198 |
| 70 | MAP4K2 | 0.69875287 |
| 71 | WNK1 | 0.68969739 |
| 72 | PRKCE | 0.68526738 |
| 73 | TYRO3 | 0.67927825 |
| 74 | FES | 0.67595836 |
| 75 | PRKCG | 0.67460968 |
| 76 | MAPK12 | 0.65150351 |
| 77 | MAPKAPK5 | 0.63693604 |
| 78 | SGK1 | 0.63641394 |
| 79 | PTK2B | 0.63590473 |
| 80 | BRD4 | 0.62823085 |
| 81 | MINK1 | 0.61301724 |
| 82 | STK38L | 0.60857427 |
| 83 | ERBB4 | 0.59235625 |
| 84 | CAMK1 | 0.58914405 |
| 85 | TRIM28 | 0.57965840 |
| 86 | BMPR1B | 0.57637222 |
| 87 | PRKAA2 | 0.57428803 |
| 88 | CAMKK1 | 0.56290018 |
| 89 | FER | 0.55755350 |
| 90 | CSNK1D | 0.55045193 |
| 91 | PRKCZ | 0.54958691 |
| 92 | MAP3K14 | 0.54556339 |
| 93 | PRKCH | 0.53745106 |
| 94 | PDGFRA | 0.52765882 |
| 95 | PDGFRB | 0.52318031 |
| 96 | ROCK1 | 0.51904568 |
| 97 | MET | 0.51202505 |
| 98 | ERBB2 | 0.50817966 |
| 99 | PRKCB | 0.50314576 |
| 100 | FGR | 0.48316660 |
| 101 | FRK | 0.47995730 |
| 102 | IRAK1 | 0.47267922 |
| 103 | MAPK15 | 0.47123137 |
| 104 | PRKG1 | 0.46904532 |
| 105 | TAOK3 | 0.46733055 |
| 106 | CSNK1G3 | 0.46381435 |
| 107 | BCR | 0.45986097 |
| 108 | RPS6KA3 | 0.45903239 |
| 109 | RPS6KB2 | 0.44745296 |
| 110 | STK11 | 0.44277447 |
| 111 | KSR1 | 0.44141210 |
| 112 | UHMK1 | 0.44116410 |
| 113 | ICK | 0.43876401 |
| 114 | CAMK2B | 0.43787366 |
| 115 | MKNK1 | 0.42007237 |
| 116 | WNK4 | 0.41770639 |
| 117 | PRKACA | 0.41281689 |
| 118 | RET | 0.41182300 |
| 119 | PRKACB | 0.40541344 |
| 120 | CSNK1A1L | 0.37645153 |
| 121 | MAPK10 | 0.37625976 |
| 122 | SIK3 | 0.36244033 |
| 123 | PRKD3 | 0.35986957 |
| 124 | WNK3 | 0.35169928 |
| 125 | MAP3K1 | 0.34725068 |
| 126 | CAMK4 | 0.34646903 |
| 127 | TSSK6 | 0.33881748 |
| 128 | CSNK1A1 | 0.32251067 |
| 129 | ROCK2 | 0.30943322 |
| 130 | RPS6KB1 | 0.30092177 |
| 131 | STK3 | 0.29191289 |
| 132 | DMPK | 0.28653616 |
| 133 | GSK3B | 0.28045669 |
| 134 | PRKCA | 0.27485641 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.71798034 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 2.59500016 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.37081363 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.27922230 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.16452954 |
| 6 | Morphine addiction_Homo sapiens_hsa05032 | 2.15570673 |
| 7 | Phototransduction_Homo sapiens_hsa04744 | 11.0632732 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.92490783 |
| 9 | Circadian entrainment_Homo sapiens_hsa04713 | 1.83768275 |
| 10 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.64871636 |
| 11 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.58302264 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.52433659 |
| 13 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.51486735 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 1.49841937 |
| 15 | Salivary secretion_Homo sapiens_hsa04970 | 1.20294505 |
| 16 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.19439483 |
| 17 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.19392952 |
| 18 | Bile secretion_Homo sapiens_hsa04976 | 1.18620102 |
| 19 | Cocaine addiction_Homo sapiens_hsa05030 | 1.14975456 |
| 20 | Taste transduction_Homo sapiens_hsa04742 | 1.14683366 |
| 21 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.13191373 |
| 22 | Circadian rhythm_Homo sapiens_hsa04710 | 1.12184835 |
| 23 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.11550309 |
| 24 | Renin secretion_Homo sapiens_hsa04924 | 1.09111620 |
| 25 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.05335204 |
| 26 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.03773367 |
| 27 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.01549776 |
| 28 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.99762639 |
| 29 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.99625613 |
| 30 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.99166363 |
| 31 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.97397280 |
| 32 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.95902206 |
| 33 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.94555090 |
| 34 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.93683124 |
| 35 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.90628592 |
| 36 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.90057074 |
| 37 | Long-term depression_Homo sapiens_hsa04730 | 0.88225261 |
| 38 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.87386248 |
| 39 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.84283510 |
| 40 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.83945025 |
| 41 | Long-term potentiation_Homo sapiens_hsa04720 | 0.83220253 |
| 42 | Basal transcription factors_Homo sapiens_hsa03022 | 0.82873324 |
| 43 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.81799758 |
| 44 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.80838897 |
| 45 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.78101341 |
| 46 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.77890962 |
| 47 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.75299449 |
| 48 | Histidine metabolism_Homo sapiens_hsa00340 | 0.74964367 |
| 49 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.74216329 |
| 50 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.72456248 |
| 51 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.71428164 |
| 52 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.71398819 |
| 53 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.71051117 |
| 54 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.70934072 |
| 55 | Axon guidance_Homo sapiens_hsa04360 | 0.70422736 |
| 56 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.69374771 |
| 57 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.69080082 |
| 58 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.68473066 |
| 59 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.68116101 |
| 60 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.66449920 |
| 61 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.65602916 |
| 62 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.65366646 |
| 63 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.64201169 |
| 64 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.64125446 |
| 65 | Protein export_Homo sapiens_hsa03060 | 0.63603015 |
| 66 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.62491270 |
| 67 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.62403191 |
| 68 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.62124741 |
| 69 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.61976219 |
| 70 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.61313428 |
| 71 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.61145024 |
| 72 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.60742890 |
| 73 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.60208874 |
| 74 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.59305987 |
| 75 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.59148989 |
| 76 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.57735820 |
| 77 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.57372967 |
| 78 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.55797329 |
| 79 | Gap junction_Homo sapiens_hsa04540 | 0.55347331 |
| 80 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.55076791 |
| 81 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.53674614 |
| 82 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.53084028 |
| 83 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.52207291 |
| 84 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.49618312 |
| 85 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.48527272 |
| 86 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.48294281 |
| 87 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.47760192 |
| 88 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.47735619 |
| 89 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.47332914 |
| 90 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.46498180 |
| 91 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.46062681 |
| 92 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.44888411 |
| 93 | ABC transporters_Homo sapiens_hsa02010 | 0.44800452 |
| 94 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.43940166 |
| 95 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.43405972 |
| 96 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.43301043 |
| 97 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.43222368 |
| 98 | Glioma_Homo sapiens_hsa05214 | 0.42517706 |
| 99 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.41027956 |
| 100 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.40869566 |
| 101 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.40277724 |
| 102 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.39283797 |
| 103 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.38370629 |
| 104 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.37785012 |
| 105 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.35976931 |
| 106 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.35567063 |
| 107 | Melanogenesis_Homo sapiens_hsa04916 | 0.34010953 |
| 108 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.31807612 |
| 109 | Mineral absorption_Homo sapiens_hsa04978 | 0.31805861 |
| 110 | Phagosome_Homo sapiens_hsa04145 | 0.31523539 |
| 111 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.30889179 |
| 112 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.29581894 |
| 113 | Alcoholism_Homo sapiens_hsa05034 | 0.29530117 |
| 114 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.29374290 |
| 115 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.28313367 |
| 116 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.28166789 |
| 117 | Melanoma_Homo sapiens_hsa05218 | 0.28080427 |
| 118 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.26624283 |
| 119 | Other glycan degradation_Homo sapiens_hsa00511 | 0.26464499 |
| 120 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.25920640 |
| 121 | Retinol metabolism_Homo sapiens_hsa00830 | 0.25021997 |
| 122 | Lysosome_Homo sapiens_hsa04142 | 0.23287693 |
| 123 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.22574671 |
| 124 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.21839195 |
| 125 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.21025683 |
| 126 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.20679519 |
| 127 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.20220330 |
| 128 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.19517530 |
| 129 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.19034081 |
| 130 | Tight junction_Homo sapiens_hsa04530 | 0.17347755 |
| 131 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.15525586 |

